openPR Logo
Press release

Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030, Evaluates DelveInsight | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPo

06-18-2025 10:01 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030,

According to DelveInsight's analysis, the increasing demand for coronary stents is largely driven by the rising incidence of cardiovascular diseases and the growing risk factors linked to coronary artery disease. Moreover, the global surge in minimally invasive surgical procedures, combined with ongoing technological advancements in stent design, are significant contributors to the anticipated growth of the coronary stents market between 2024 and 2030.

DelveInsight's "Coronary Stents Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Coronary Stents companies actively working in the market.

To know more about why North America is leading the market growth in the Coronary Stents market, get a snapshot of the report Coronary Stents Market Trends
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Coronary Stents Overview
Coronary stents are small, mesh-like tubes inserted into narrowed or blocked coronary arteries to keep them open and restore proper blood flow to the heart. They are commonly used during angioplasty procedures to treat coronary artery disease (CAD) and help prevent heart attacks or chest pain. Some stents are drug-eluting, releasing medication to prevent re-narrowing of the artery.

DelveInsight Analysis: The coronary stents market was valued at USD 9.27 billion in 2023 and is projected to grow at a CAGR of 7.51% from 2024 to 2030, reaching USD 14.28 billion by the end of the forecast period.

Coronary Stents Market Insights
Geographically, North America is projected to lead the coronary stents market throughout the forecast period. This leadership is due to the growing incidence of heart-related conditions, increased efforts by governments and organizations to promote awareness about cardiovascular health, and notable technological progress and product innovations by major companies in the region.

To read more about the latest highlights related to Coronary Stents, get a snapshot of the key highlights entailed in the Coronary Stents Market Landscape
https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Coronary Stents Market Report
• In July 2024, BIOTRONIK introduced the Maximum Allowed Diameters (MAD) range for its Orsiro Mission drug-eluting stent (DES) as part of a global initiative to enhance the stent's capabilities. This development supports current percutaneous coronary intervention (PCI) techniques by enabling physicians to achieve better vessel apposition and accommodate tapered anatomies more efficiently.
• In April 2023, Terumo Corporation announced the launch of a new prospective clinical study evaluating the Ultimaster NagomiTM sirolimus-eluting coronary stent system in patients undergoing complex PCI procedures. This stent system retains the sirolimus-eluting drug while featuring an improved delivery mechanism and enhanced effectiveness in treating coronary artery disease. The main objective of the study is to evaluate the clinical outcomes in patients treated with the Ultimaster NagomiTM stent during complex interventions.
• In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems, Inc. for USD 890 million. This strategic move enhances Abbott's portfolio of advanced stent systems and strengthens its technological expertise in interventional vascular devices, supporting broader global market expansion.
• In July 2022, MicroPort Scientific Corporation has received marketing approval from China's National Medical Products Administration (NMPA) for its Firehawk ProTM Coronary Rapamycin Target Eluting Stent System. Designed with a balloon-expandable structure and a groove-binding, single-sided drug coating, this advanced stent system is intended for treating symptomatic primary coronary artery lesions. The drug coating works to prevent smooth muscle cell growth at the lesion site, aiding in arterial support and minimizing the risk of restenosis.
• Thus, owing to such developments in the market, rapid growth will be observed in the Coronary Stents market during the forecast period

Key Players in the Coronary Stents Market
Some of the key market players operating in the Coronary Stents market include- Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others.

Which MedTech key players in the Coronary Stents market are set to emerge as the trendsetter explore @ Key Coronary Stents Companies
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Coronary Stents Market Landscape
The rising adoption of minimally invasive procedures like coronary angioplasty and percutaneous coronary intervention (PCI) plays a key role in driving the growth of the coronary stent market. According to data released by Eurostat, the European Union's statistical office, in October 2023, around 1.1 million percutaneous coronary angioplasty procedures were carried out across Europe in 2021.

Recent product approvals are anticipated to boost the coronary stent market's growth. Leading companies are ramping up research and development to introduce advanced drug-eluting stents for managing coronary artery disease (CAD). For instance, in August 2022, Medtronic launched the Onyx FrontierTM, its latest drug-eluting stent, following CE Mark approval. This stent features an enhanced delivery system and builds on the clinical success of the Resolute OnyxTM. Specifically designed for CAD patients-who suffer from plaque accumulation in the coronary arteries-such innovations are expected to improve treatment outcomes and significantly contribute to market expansion.

Scope of the Coronary Stents Market Report
• Coverage: Global
• Study Period: 2021-2030
• Coronary Stents Market Segmentation By Product Type: Bare Metal Stents, Drug Eluting Stents, and Bioresorbable Scaffolds), Material (Metal [Stainless Steel, Cobalt-Chromium {CoCr}, Platinum-Chromium {PtCr}, Nitinol], and Polymer
• Coronary Stents Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Coronary Stents Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Coronary Stents Companies: Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Coronary Stents market will grow by 2030? Click to get a snapshot of the Coronary Stents Market Analysis
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Coronary Stents Market Report Introduction
2 Coronary Stents Market Executive summary
3 Regulatory and Patent Analysis
4 Coronary Stents Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Coronary Stents Market
7 Coronary Stents Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11 Coronary Stents Market Drivers
12 Coronary Stents Market Barriers
13 About DelveInsight

Latest Reports by DelveInsight
• Scoliosis Market: https://www.delveinsight.com/report-store/scoliosis-market
• Psoriasis Market: https://www.delveinsight.com/report-store/psoriasis-market
• Tendinitis Market: https://www.delveinsight.com/report-store/tendonitis-market
• Vascular Closure Devices Market: https://www.delveinsight.com/report-store/vascular-closure-devices-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Hydrocephalus Market: https://www.delveinsight.com/report-store/hydrocephalus-market
• Hemophilia A Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Herpes Simplex Virus Market: https://www.delveinsight.com/report-store/genital-herpes-market
• Peripheral Nerve Injuries Market: https://www.delveinsight.com/infographics/peripheral-nerve-injuries-market

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030, Evaluates DelveInsight | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPo here

News-ID: 4072960 • Views:

More Releases from DelveInsight Business Research

Global Uterine Manipulators Market to grow at a CAGR of 5.64% by 2032, Evaluates DelveInsight | CONMED Corporation, KARL STORZ, Olympus Corporation, Richard Wolf GmbH, Hologic, Inc., Lumenis Be Ltd., B. Braun Melsungen AG, Medline Industries, LP, EndoMed
Global Uterine Manipulators Market to grow at a CAGR of 5.64% by 2032, Evaluates …
According to DelveInsight's analysis, North America is projected to dominate the uterine manipulators market in 2024, primarily due to the growing incidence of gynecological conditions and the rising number of uterine and endometrial cancer cases. Ongoing technological innovations and continuous product advancements in uterine manipulators are also driving market expansion. Furthermore, the region's advanced healthcare infrastructure, featuring cutting-edge hospitals and specialized cancer treatment facilities, promotes the adoption of sophisticated surgical
Global Uterine Fibroids Treatment Devices Market to grow at a CAGR of 8.57% by 2032, Evaluates DelveInsight | Hologic, Inc., Merit Medical Systems, Insightec, Boston Scientific Corporation, Profound Medical, Olympus Corporation, Medtronic, Intuitive Surgi
Global Uterine Fibroids Treatment Devices Market to grow at a CAGR of 8.57% by 2 …
According to DelveInsight's analysis, The growing prevalence of uterine fibroids, especially among women of reproductive age, is driving the demand for effective treatment devices. Increased awareness of the condition and better access to healthcare services are also contributing to earlier diagnoses and timely treatment. In addition, technological progress has led to the creation of minimally invasive and highly efficient treatment devices, improving patient outcomes and shortening recovery periods. Key players
Global Artificial Intelligence (AI) in Remote Patient Monitoring Market to grow at a CAGR of 27.13% by 2032, Evaluates DelveInsight | Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofou
Global Artificial Intelligence (AI) in Remote Patient Monitoring Market to grow …
According to DelveInsight's analysis, North America is projected to lead the Artificial Intelligence (AI) in Remote Patient Monitoring market throughout the 2025 to 2032 forecast period. This growth is primarily driven by the increasing prevalence of chronic conditions like cancer, a robust healthcare infrastructure, widespread adoption of digital health solutions, and favorable government initiatives. Additionally, the region is seeing significant investments in digital health and extensive utilization of wearable and
Global Artificial Intelligence (AI) in Precision Medicine Market to grow at a CAGR of 33.18% by 2032, Evaluates DelveInsight | TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Preno
Global Artificial Intelligence (AI) in Precision Medicine Market to grow at a CA …
According to DelveInsight's analysis, The Artificial Intelligence in Precision Medicine market is experiencing notable growth, largely due to the increasing global burden of chronic and genetic disorders, which has heightened the demand for personalized treatment approaches. This growth is further supported by the rising need for precision diagnostics and customized therapies, where AI excels at interpreting complex biological datasets. Ongoing technological advancements in AI-driven platforms, coupled with the development of

All 5 Releases


More Releases for Stent

Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still